Dr. Will Parsons is a member of the Crazy 8 team studying newborn screening for early childhood cancer predisposition syndromes.

He is the Beverly and Daniel C. Arnold Endowed Chair for Precision Medicine at Texas Children's Hospital and Interim Director of Texas Children’s Cancer and Hematology Center, Baylor College of Medicine (BCM). He also serves as Pediatrician-in-Chief for Baylor College of Medicine's Dan L. Duncan Comprehensive Cancer Center. He is a board-certified pediatric hematologist-oncologist who also serves as Co-Director of the Cancer Genetics and Genomics Program, and Director of the Center for Precision Oncology within Texas Children’s Cancer Center. Dr. Parsons has distinguished himself as one of the country’s leaders in the field of cancer genomics and the use of “precision oncology” approaches for the diagnosis and treatment of children with high-risk and relapsed cancers.

In addition to conducting innovative translational research in pediatric cancer genomics, Dr. Parsons and his team are making important contributions to the clinical care of childhood cancer patients, including establishment of the Precision Oncology Consultation Service at Texas Children’s Cancer Center, which provides recommendations for the use and interpretation of clinical genomic testing for pediatric cancer patients nationwide. He also plays leadership roles within the National Cancer Institute (NCI)-funded Pediatric Brain Tumor Consortium (PBTC) and the Children’s Oncology Group (COG), the world’s largest organization devoted exclusively to pediatric cancer research, including serving as the COG study chair for the NCI-COG Pediatric MATCH trial and as the Genomics and Translational Biology Committee lead for the COG Pediatric Early Phase-Clinical Trial Network (PEP-CTN).